Pharmaceutical Chief IP Counsel sit at the helm of the Hatch-Waxman litigation nerve center where they navigate the ever-evolving landscape of pharmaceutical patent litigation. With the intent of IP protection preservation or defeat at the forefront of their agendas, these panelists will discuss best practices and strategies they employ to control or covet patents and profits.

Brand Perspectives

• Appreciating the importance of patents for innovation
• Understanding the keys to growing a strong portfolio
• Orange Book listing strategies
• Gauging when to expect a Paragraph IV lawsuit

Generic Perspectives

• Determining which patents are ripe to challenge in today’s environment
• What makes one patent more attractive than another?
• Evaluating invalidity and non-infringement for the patent target
• Formulating your ANDA strategy

Considerations for Both Sides

• Deciding when to refer to outside counsel and detailing which matters typically remain in-house
• Taking stock of significantly challenging situations and predicting the challenges in-house lawyers will face in the future